| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2K | -15.4% |
| R&D Expense | $513K | -9.6% |
| SG&A Expense | $396K | -5.6% |
| Operating Income | -$2.5M | -108.1% |
| Interest Expense | $73K | +559.1% |
| Pre-tax Income | -$3.3M | -172.1% |
| Net Income | -$3.3M | -172.1% |
| EPS (Basic) | -$0.47 | -135.0% |
| EPS (Diluted) | -$0.47 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $259K | -77.6% |
| Current Assets | $266K | -77.1% |
| Total Assets | $415K | -64.2% |
| Current Liabilities | $66K | -27.9% |
| Total Liabilities | $66K | -27.9% |
| Stockholders' Equity | $349K | -67.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.3M | -114.6% |
| Capital Expenditures | $8K | — |
| Investing Cash Flow | -$176K | — |
| Financing Cash Flow | $1.6M | -11.5% |
| Free Cash Flow | -$2.3M | — |
| -135.0% |